Cargando…

Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer

The efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small-cell lung cancer (NSCLC) might depend on the presence of emphysema, but this association is not established. We aimed to investigate if quantitively and automatically measuring emphysema can predict the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noda, Yoshimi, Shiroyama, Takayuki, Masuhiro, Kentaro, Amiya, Saori, Enomoto, Takatoshi, Adachi, Yuichi, Hara, Reina, Niitsu, Takayuki, Naito, Yujiro, Miyake, Kotaro, Koyama, Shohei, Hirata, Haruhiko, Nagatomo, Izumi, Takeda, Yoshito, Kumanogoh, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133115/ https://www.ncbi.nlm.nih.gov/pubmed/35614345 http://dx.doi.org/10.1038/s41598-022-13131-2

Ejemplares similares

COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation
por: Noda, Yoshimi, et al.
Publicado: (2021)

Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review
por: Niitsu, Takayuki, et al.
Publicado: (2020)

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
por: Enomoto, Takatoshi, et al.
Publicado: (2022)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
por: Amiya, Saori, et al.
Publicado: (2021)

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema
por: Yamamoto, Yuji, et al.
Publicado: (2022)

Lateral Decubitus Position Enables Further Advancement of the Bronchoscope into the Lung Periphery
por: Miyake, Kotaro, et al.
Publicado: (2022)

Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study
por: Adachi, Yuichi, et al.
Publicado: (2021)

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
por: Tone, Mari, et al.
Publicado: (2023)

Pulmonary metastases of lung adenocarcinoma mimicking COVID-19 pneumonia
por: Shiroyama, Takayuki, et al.
Publicado: (2020)

Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan
por: Takata, So, et al.
Publicado: (2022)

Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
por: Shiroyama, Takayuki, et al.
Publicado: (2019)

A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity
por: Nakagawa, Yuta, et al.
Publicado: (2022)

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
por: Iwahori, Kota, et al.
Publicado: (2022)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
por: Osa, Akio, et al.
Publicado: (2019)

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19
por: Kawasaki, Takahiro, et al.
Publicado: (2022)

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination
por: Amiya, Saori, et al.
Publicado: (2022)

Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing
por: Takata, So, et al.
Publicado: (2022)

A lung abscess caused by secondary syphilis – the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report
por: Futami, Shinji, et al.
Publicado: (2019)

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report
por: Naito, Maiko, et al.
Publicado: (2023)

Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports
por: Koba, Taro, et al.
Publicado: (2017)

Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
por: Maeda, Yuichi, et al.
Publicado: (2022)

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
por: Futami, Yu, et al.
Publicado: (2022)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment
por: Koyama, Shohei, et al.
Publicado: (2018)

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
por: Otsuka, Tomoyuki, et al.
Publicado: (2022)

Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID‐19
por: Yamamoto, Yuji, et al.
Publicado: (2023)

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
por: Koba, Taro, et al.
Publicado: (2021)

Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8(+) T cell cytotoxicity and proliferation
por: Naito, Yujiro, et al.
Publicado: (2023)

Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
por: Masuhiro, Kentaro, et al.
Publicado: (2022)

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis
por: Minami, Toshiyuki, et al.
Publicado: (2013)

Semaphorin 6D–expressing mesenchymal cells regulate IL-10 production by ILC2s in the lung
por: Naito, Maiko, et al.
Publicado: (2022)

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
por: Osa, Akio, et al.
Publicado: (2018)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
por: Kuge, Tomoki, et al.
Publicado: (2023)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging
por: Jin, Yingji, et al.
Publicado: (2018)

Integrative Analysis Reveals Common and Unique Roles of Tetraspanins in Fibrosis and Emphysema
por: Tripathi, Lokesh P., et al.
Publicado: (2020)

Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis
por: Kinehara, Yuhei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tasgrqod5dem430k7i4ueonmm9